Riskpilot← Back to searchSign inGet full accessRenaissance Clinique AB
ABActiveOrg 5567278816Södra Kajen 37Medical specialists activities · NACE 8622Est. 20071-4 employees
Revenue 2024
SEK 3,5M
+90% vs 2023
EBITDA margin
-13.1%
+75% vs 2023
Equity ratio
85.1%
Financial strength
Net profit 2024
SEK -558K
+71% vs 2023
| Revenue | SEK 3,5M | +90% |
| EBITDA | SEK -463K | +75% |
| Net profit | SEK -558K | +71% |
| Total assets | SEK 1,6M | -22% |
| Equity | SEK 1,4M | -29% |
| Employees | — | — |
Legal name
Renaissance Clinique AB
Org number
5567278816
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 april 2007
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva estetisk plastkirurgi, laserkirurgi och kosmetisk dermatologi.
Address
Södra Kajen 37
Email
info@renaissanceclinique.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 778 | 3 366 | 3 182 | 1 852 | 3 524 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 857 | −337 | 2 296 | −1 846 | −463 |
| Depreciation & amort. | −89 | −89 | −48 | −94 | −94 |
| EBIT | 1 768 | −426 | 2 248 | −1 940 | −557 |
| Net financials | −10 | — | 4 | 24 | −1 |
| Profit before tax | 1 757 | −426 | 2 252 | −1 915 | −558 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 757 | −426 | 2 252 | −1 915 | −558 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 451 | 2 244 | — | 2 036 | 1 591 |
| Equity | 2 002 | 1 575 | — | 1 912 | 1 354 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 449 | 669 | — | 124 | 237 |
| Total debt | 449 | 669 | — | 124 | 237 |
EBITDA margin
-13.1%
This company
15.8%
Market median
-183% vs market
20202024
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
-41.2%
This company
18.4%
Market median
-324% vs market
20202024
Net profit margin
-15.8%
This company
8.1%
Market median
-295% vs market
20202024
Asset turnover
2.21×
This company
1.12×
Market median
+97% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CA Audit | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2026 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Renaissance Clinique AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Almstedt | Audit | 0 companies |
| Rex Lincoln Christian K Montroyal | Board of Directors | 0 companies |
| Sayed Ziaedin Mirhosseni | Deputy Board Member | 0 companies |
| Eva Maria Persson | Deputy Board Member | 0 companies |